Clinical trials ‘push the envelope’ to test new therapies for melanoma
J. Harrison Howard, M.D., praised the USA Health Mitchell Cancer Institute's multidisciplinary clinic that focuses on melanoma.
Posted 1 year agoRead Story >
About J. Harrison Howard, M.D., F.A.C.S.
Dr. Howard has been involved in cutting edge immunotherapy trials for melanoma and has been involved with the National Comprehensive Cancer Network (NCCN) practice guideline development. He has been published numerous times and his research has been presented at regional, national and international meetings.
Prior to his appointment with USA Health, Dr. Howard served as an assistant professor of surgery at the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at The Ohio State University. He will focus his practice at USA Health on the treatment of melanoma, sarcoma and GI malignancies.
A native of Birmingham, Dr. Howard earned his medical degree at the University of Alabama at Birmingham and completed his residency at UAB Hospital. He served as a surgical oncology fellow at the John Wayne Cancer Institute in Santa Monica, California. He is board certified in general surgery.
